A detailed history of Affinity Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Affinity Investment Advisors, LLC holds 18,192 shares of BMY stock, worth $1.07 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
18,192
Previous 18,075 0.65%
Holding current value
$1.07 Million
Previous $750,000 25.47%
% of portfolio
0.65%
Previous 0.56%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$39.66 - $51.75 $4,640 - $6,054
117 Added 0.65%
18,192 $941,000
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $5,957 - $7,842
-148 Reduced 0.81%
18,075 $750,000
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $2,015 - $2,284
-42 Reduced 0.23%
18,223 $988,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $103,747 - $123,799
-2,140 Reduced 10.49%
18,265 $937,000
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $33,749 - $37,737
-583 Reduced 2.78%
20,405 $1.18 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $314,345 - $349,031
-4,934 Reduced 19.03%
20,988 $1.34 Million
Q1 2023

May 05, 2023

SELL
$65.71 - $74.53 $1.09 Million - $1.24 Million
-16,594 Reduced 39.03%
25,922 $1.8 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $72 - $42,569
-554 Reduced 1.29%
42,516 $3.02 Million
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $32,388 - $35,671
-446 Reduced 1.02%
43,070 $3.32 Million
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $18,566 - $22,263
-302 Reduced 0.69%
43,516 $3.18 Million
Q4 2021

Feb 04, 2022

SELL
$53.63 - $62.52 $219,346 - $255,706
-4,090 Reduced 8.54%
43,818 $2.73 Million
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $20,650 - $24,189
-349 Reduced 0.72%
47,908 $2.84 Million
Q2 2021

Aug 09, 2021

SELL
$61.91 - $67.42 $1.17 Million - $1.27 Million
-18,910 Reduced 28.15%
48,257 $3.23 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $94,944 - $106,783
-1,600 Reduced 2.33%
67,167 $4.24 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $162,307 - $183,923
-2,811 Reduced 3.93%
68,767 $4.27 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $214,730 - $237,949
3,739 Added 5.51%
71,578 $4.32 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $494,257 - $577,835
-9,016 Reduced 11.73%
67,839 $3.99 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $77,580 - $112,742
-1,672 Reduced 2.13%
76,855 $4.28 Million
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $707,442 - $922,795
-14,376 Reduced 15.47%
78,527 $5.04 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $143,022 - $169,574
-3,344 Reduced 3.47%
92,903 $4.71 Million
Q2 2019

Aug 08, 2019

SELL
$44.62 - $49.34 $2.68 Million - $2.97 Million
-60,110 Reduced 38.44%
96,247 $4.37 Million
Q1 2019

May 07, 2019

SELL
$45.12 - $53.8 $1.94 Million - $2.31 Million
-43,027 Reduced 21.58%
156,357 $7.46 Million
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $865,490 - $1.12 Million
-17,750 Reduced 8.17%
199,384 $10.4 Million
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $12 Million - $13.5 Million
217,134 New
217,134 $13.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Affinity Investment Advisors, LLC Portfolio

Follow Affinity Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Investment Advisors, LLC with notifications on news.